KAKaladerhan Osemwengie Agbontaen

Kaladerhan Osemwengie Agbontaen

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Kaladerhan Osemwengie Agbontaen has a total of 31 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Evaluating inter-and intra-rater reliability in the bronchoscopic grading of burn inhalation injury: The iBRONCH-BII study

    by Eleana T. Kumana, Walton N. Charles, Helena Milton-Jones, Kaladerhan Agbontaen, Sabri Soussi, Ken Dunn, Roger Davies, Joanne Atkins, Ceri Beynon, Emmanuel Charbonney, et al.


  • Top Cited Papers
    Open Access

    Artificial Intelligence-Guided Bronchoscopy is Superior to Human Expert Instruction for the Performance of Critical-Care Physicians: A Randomized Controlled Trial

    by Kaladerhan O. Agbontaen, Kristoffer M. Cold, David Woods, Vimal Grover, Hatem Soliman Aboumarie, Sundeep Kaul, Lars Konge, Suveer Singh

    OBJECTIVES: Bronchoscopy in the mechanically ventilated patient is an important skill for critical-care physicians. However, training opportunity is heterogenous and limited by infrequent caseload or inadequate instructor feedback for satisfactory competencies. A new artificial intelligence (AI) navigational system using augmented reality – the Ambu Broncho Simulator – can guide bronchoscopy training. Is training with the AI system comparable to bedside, expert tutor instruction in improving bronchoscopy performance? DESIGN: A nonblinded, parallel group randomized controlled trial was conducted. SETTING: The study was conducted in a simulated setting at an academic university hospital. SUBJECTS: Critical-care physicians were invited to take part in the study. INTERVENTIONS: Forty participants received 30 minutes of bronchoscopy training, either guided by AI only (artificial intelligence group [AIG]) or by expert tutor feedback (expert tutor group [ETG]). All participants performed a final full navigation bronchoscopy performance test and completed a cognitive load questionnaire, the NASA Task Load Index . MEASUREMENTS AND MAIN RESULTS: Mean intersegmental time (MIT = PT/DC), diagnostic completeness (DC), procedure time (PT), structured progress (SP), and number of segments revisited (SR) were measured. The primary outcome measure assessed was MIT, a measure of bronchoscopic performance efficiency. The secondary outcome measures were DC, PT, SP, and SR. Nineteen participants were randomized to the AIG and 21 participants to the ETG. MIT, PT, and SR were significantly better in the AIG compared to the ETG (median difference, p): MIT (–7.9 s, 0.027), PT (–77 s, 0.022), SR (–7 segments, 0.019); all showing moderate effect sizes (0.35, 0.36, and 0.37, respectively) as per Cohen’s classification. There was no significant difference between the groups for all other final test measures. CONCLUSIONS: Training using an AI system resulted in faster and more efficient bronchoscopy performance by critical-care physicians when compared to expert human tutor instruction. This could change the future of bronchoscopy training in critical care and warrants validation in patients through clinical studies.


  • Open Access

    Critical COVID-19 in a 24-week pregnant woman with 32 days of invasive mechanical ventilation before delivery of fetus: a case of successful collaborative multidisciplinary care

    by Kaladerhan Osemwengie Agbontaen, Khevan Somasundram, Matthew Baker

    We describe the successful treatment of a 24-week pregnant, 44-year-old woman with COVID-19. Management of this complex case required multidisciplinary collaboration and included prolonged invasive mechanical ventilation and prone positioning. Caesarean section delivery was delayed for 32 days, with no monitored fetal compromise, while stabilising the mother. To our knowledge, this is the longest reported duration of invasive ventilation while pregnant in a patient with COVID-19. COVID-19 has been shown to cause increased disease severity in pregnant women, and certain pregnancy-related physiological adaptations that occur could help explain this association. While COVID-19 has been shown to cause no increased adverse neonatal outcomes, clinicians should be aware that data show increased preterm birth in symptomatic pregnant women, thereby increasing the chance of prematurity-related complications. Further research on COVID-19 in pregnancy is crucial to facilitate better management, and full inclusion of pregnant women in therapeutic clinical trials will help achieve this.